Read More 24 minute read Earnings Earnings Scheduled For November 8, 2023 By Benzinga Insights November 8, 5:21 AM Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its third quarter. AADI
Read More 4 minute read Biotech General News Adaptimmune Reports Better Outcomes For People With Synovial Sarcoma Who Received Afami-cel Compared To Historical Control By Benzinga Newsdesk October 31, 8:14 AM ~39% of patients who received afami-cel in the pivotal SPEARHEAD-1 trial had clinical responses with a median duration of response of ~12 months (CTOS 2022)Median overall survival (mOS) was ~17 months in SPEARHEAD-1 ADAP
Read More 17 minute read Options Stocks That Hit 52-Week Lows On Tuesday By Benzinga Insights September 19, 12:50 PM During Tuesday's session, 275 companies made new 52-week lows. ABCL
Read More 14 minute read Options Stocks That Hit 52-Week Lows On Friday By Benzinga Insights September 8, 1:58 PM Friday's session saw 225 companies set new 52-week lows. AAMC
Read More 17 minute read Options Stocks That Hit 52-Week Lows On Thursday By Benzinga Insights September 7, 1:55 PM On Thursday, 283 companies set new 52-week lows. AAMC
Read More 2 minute read Movers 12 Health Care Stocks Moving In Friday’s After-Market Session By Benzinga Insights August 25, 5:31 PM Gainers MSP Recovery (NASDAQ:LIFW) stock increased by 14.0% to $0.08 during Friday’s after-market session. At the close, MSP… ADAP
Read More 2 minute read Movers 12 Health Care Stocks Moving In Thursday’s After-Market Session By Benzinga Insights August 24, 5:32 PM Gainers YS Biopharma Co (NASDAQ:YS) stock rose 43.0% to $1.08 during Thursday’s after-market session. Today’s trading volume for… ADAP
Read More 9 minute read Options Stocks That Hit 52-Week Lows On Thursday By Benzinga Insights August 10, 1:43 PM On Thursday, 128 companies set new 52-week lows. ADAP
Read More 2 minute read Analyst Ratings Analyst Expectations for Adaptimmune Therapeutics’s Future By Benzinga Insights August 10, 8:00 AM Over the past 3 months, 5 analysts have published their opinion on Adaptimmune Therapeutics (NASDAQ:ADAP) stock. These analysts… ADAP
Read More 5 minute read Options Stocks That Hit 52-Week Lows On Friday By Benzinga Insights July 28, 12:36 PM Friday's session saw 59 companies set new 52-week lows. AADI